青松股份(300132.SZ):全資子公司取得3項實用新型專利
格隆匯12月14日丨青松股份(300132.SZ)公佈,公司全資子公司諾斯貝爾化粧品股份有限公司(以下簡稱“諾斯貝爾”)與福建南平青松化工有限公司(以下簡稱“青松化工”)近日分別收到了國家知識產權局頒發的《實用新型專利證書》,分別為一種凍乾麪膜包裝紙盒,本實用新型涉及一種凍乾麪膜,由紙板製成,環保;儲存時可以疊置,佔用空間小;包裝面膜後,體積小,降低了包裝成本;
一種帶鏟子的濕巾蓋,本實用新型涉及包裝領域,由於採用這樣的結構,消費者使用時,濕巾擦拭去污,遇到難以清除的油污,可以隨手取出鏟子剷除,使用方便,不需要消費者另外配置工具;
一種樟腦凝華室尾氣回收裝置,本實用新型涉及製藥領域,所述的尾氣回收裝置能夠簡單和有效地用於對樟腦凝華室的樟腦尾氣進行吸收,且避免吸收液倒吸的發生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.